WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Cytokinetics, Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-08 10:11 am Sale | 2023-12-29 | 13G | Cytokinetics, Incorporated CYTK | WELLINGTON MANAGEMENT CO LLP | 6,530,884 6.660% | -11,840 (-0.18%) | Filing |
| 2023-02-06 2:51 pm Purchase | 2022-12-30 | 13G | Cytokinetics, Incorporated CYTK | WELLINGTON MANAGEMENT CO LLP | 6,542,724 6.910% | 6,542,724 (New Position) | Filing |